REQUEST A DEMO
Total
USD $0.00
Search more companies

Parexel International Colombia Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Parexel International Colombia Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Parexel International Colombia Sas is based in Colombia, with the head office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on August 31, 2010. It currently has a total number of 30 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 49.97% in 2023. Its total assets grew by 18.93% over the same period. Parexel International Colombia Sas’s net profit margin increased by 3.71% in 2023.

Headquarters
Cr 9 # 80-45
Bogota D.C.; Bogota D.C; Postal Code: 0805

Contact Details: Purchase the Parexel International Colombia Sas report to view the information.

Basic Information
Total Employees:
Purchase the Parexel International Colombia Sas report to view the information.
Outstanding Shares:
Purchase the Parexel International Colombia Sas report to view the information.
Incorporation Date:
August 31, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Parexel International Colombia Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
49.97%
Total operating revenue
49.97%
Operating profit (EBIT)
142.78%
Net Profit (Loss) for the Period
175.82%
Total assets
18.93%
Total equity
21.9%
Operating Profit Margin (ROS)
5.54%
Net Profit Margin
3.71%
Return on Equity (ROE)
10.03%
Quick Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?